Resveratrol: a multitargeted agent for age-associated chronic diseases

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology
• Nutraceuticals

Background:

• Chronic illnesses involve dysregulated cell signaling and inflammation.
• Current mono-targeted therapies are often ineffective and costly.
• Fruits and vegetables possess therapeutic potential, but active compounds and mechanisms are unclear.

Purpose of the Study:

• To review the diverse molecular targets of resveratrol.
• To explore the therapeutic potential of resveratrol against chronic diseases.
• To highlight resveratrol's multi-targeted mechanism of action.

Main Methods:

• Literature review of studies on resveratrol's molecular interactions.
• Analysis of resveratrol's effects on cell signaling pathways.
• Examination of preclinical data on resveratrol's efficacy in disease models.

Main Results:

• Resveratrol interacts with numerous cell signaling molecules and transcription factors.
• It modulates pathways involved in inflammation, apoptosis, cell cycle, and angiogenesis.
• Animal studies indicate promise against cancer, diabetes, Alzheimer's, and cardiovascular diseases.

Conclusions:

• Resveratrol's multi-targeted action offers a promising alternative to mono-targeted therapies.
• Its potential in clinical applications is growing, with ongoing efforts to enhance its efficacy.
• Further research into resveratrol's targets can accelerate its therapeutic development.